Pulgo, Jemson E.
HRN: 24-31-27 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/31/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/31/2023
01/06/2024
IVT
4.5g
Q8
Hyperglycemic Crisis; CAP MR
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes